1-7 of 7
Mark Wood
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3717: Defining optimal dose schedules for ATR inhibitors in combination with DNA damaging drugs: Informing clinical studies of VX-970, the first-in-class ATR inhibitor

John Pollard, Phil Reaper, Adele Peek, Stuart Hughes, Scott Gladwell, Julie Jones, Peter Chiu, Mark Wood, Crystal Tolman, Mac Johnson, Peter Littlewood, Marina Penney, Katherine McDermott, Brian Hare, Scott Z. Fields, Mohammed Asmal, Brent O’Carrigan, Timothy A. Yap
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3717.
https://doi.org/10.1158/1538-7445.AM2016-3717
Published: 15 July 2016
View article titled, Abstract 3717: Defining optimal dose schedules for ATR inhibitors in combination with DNA damaging drugs: Informing clinical studies of VX-970, the first-in-class ATR inhibitor
Journal Articles

Abstract 3716: Potent radiation enhancement with VX-984, a selective DNA-PKcs inhibitor for the treatment of NSCLC

Diane Boucher, Russell Hoover, Yuxin Wang, Yong Gu, David Newsome, Pamella Ford, Cameron Moody, Veronique Damagnez, Reiko Arimoto, Shawn Hillier, Mark Wood, William Markland, Brenda Eustace, Kevin Cottrell, Marina Penney, Brinley Furey, Kirk Tanner, John Maxwell, Paul Charifson
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3716.
https://doi.org/10.1158/1538-7445.AM2016-3716
Published: 15 July 2016
View article titled, Abstract 3716: Potent radiation enhancement with VX-984, a selective DNA-PKcs inhibitor for the treatment of NSCLC
Journal Articles

Abstract 1644: VX-970, the first-in-class inhibitor of the DNA damage repair enzyme ATR

John Pollard, Philip Reaper, Julie Jones, Christopher Barnes, Scott Gladwell, Stuart Hughes, Adele Peak, Hakim Djeha, Amy Hall, David Newsome, Yuxin Wang, Diane Boucher, Brenda Eustace, Yong Gu, Brian Hare, Mac Johnson, Sean Milton, Cheryl Murphy, Darin Takemoto, Crystal Tolman, Mark Wood, Brinley Furey, Marina Penney, Howard Li, Christopher Defranco, Mohammed Asmal, Scott Fields
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1644.
https://doi.org/10.1158/1538-7445.AM2015-1644
Published: 01 August 2015
View article titled, Abstract 1644: VX-970, the first-in-class inhibitor of the DNA damage repair enzyme ATR
Journal Articles

Abstract LB-299: Comprehensive preclinical evaluation of VE-822, the first ATR-targeted drug candidate: a novel approach to transforming the efficacy of DNA damaging agents.

Diane Boucher, Peter Charlton, Jean-Damien Charrier, Brinley Furey, Yong Gu, Amy Hall, Brian Hare, Howard Li, Sean Milton, Cheryl Murphy, Philip Reaper, Darin Takemoto, Taturo Udagawa, Yuxin Wang, Mark Wood, John Pollard
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): LB-299.
https://doi.org/10.1158/1538-7445.AM2013-LB-299
Published: 15 April 2013
View article titled, Abstract LB-299: Comprehensive preclinical evaluation of VE-822, the first ATR-targeted drug candidate: a novel approach to transforming the efficacy of DNA damaging agents.
Journal Articles

Chronic Suppression of Angiogenesis following Radiation Exposure Is Independent of Hematopoietic Reconstitution

Taturo Udagawa, Amy E. Birsner, Mark Wood, Robert J. D'Amato
Journal: Cancer Research
Cancer Res (2007) 67 (5): 2040–2045.
https://doi.org/10.1158/0008-5472.CAN-06-2877
Published: 01 March 2007
View article titled, Chronic Suppression of Angiogenesis following Radiation Exposure Is Independent of Hematopoietic Reconstitution
Open the PDF for Chronic Suppression of Angiogenesis following Radiation Exposure Is Independent of Hematopoietic Reconstitution in another window
Journal Articles

X-Linked Dominant Growth Suppression of Transplanted Tumors in C57BL/6J-scid Mice

Mark Wood, Taturo Udagawa, Yasuhiro Hida, Robert J. D'Amato
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5690–5695.
https://doi.org/10.1158/0008-5472.CAN-04-3573
Published: 01 July 2005
View article titled, X-Linked Dominant Growth Suppression of Transplanted Tumors in C57BL/6J-<em>scid</em> Mice
Open the PDF for X-Linked Dominant Growth Suppression of Transplanted Tumors in C57BL/6J-<em>scid</em> Mice in another window
Journal Articles

X-linked dominant growth suppression of transplanted tumors in C57BL/6J SCID mice

Mark Wood, Taturo Udagawa, Yasuhiro Hida, Robert J. D’amato
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 244.
Published: 01 May 2005
View article titled, X-linked dominant growth suppression of transplanted tumors in C57BL/6J SCID mice